FASLG and neoplasm: found that Vδ2-T cells derived EVs enriched in FasL, TRAIL, NKG2D, CD80, CD86, MHC class I and II, and these components can directly kill Epstein-Barr virus-associated tumor cells and induced T cell-mediated antitumor response (Wang et al., 2020).